Articles with public access mandates - FABIO Del BelloLearn more
Not available anywhere: 9
Synthesis of triazole-linked analogues of c-di-GMP and their interactions with diguanylate cyclase
S Fernicola, I Torquati, A Paiardini, G Giardina, G Rampioni, M Messina, ...
Journal of medicinal chemistry 58 (20), 8269-8284, 2015
Mandates: Government of Italy
Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl) propyl]-1, 2, 3, 4 …
A Bonifazi, H Yano, F Del Bello, A Farande, W Quaglia, R Petrelli, ...
Journal of medicinal chemistry 57 (21), 9065-9077, 2014
Mandates: US National Institutes of Health
1-[3-(4-Butylpiperidin-1-yl) propyl]-1, 2, 3, 4-tetrahydroquinolin-2-one (77-LH-28-1) as a model for the rational design of a novel class of brain penetrant ligands with high …
F Del Bello, A Bonifazi, G Giorgioni, C Cifani, MV Micioni Di Bonaventura, ...
Journal of medicinal chemistry 61 (8), 3712-3725, 2018
Mandates: US National Institutes of Health
The replacement of the 2-methoxy substituent of N-((6, 6-diphenyl-1, 4-dioxan-2-yl) methyl)-2-(2-methoxyphenoxy) ethan-1-amine improves the selectivity for 5-HT1A receptor over …
F Del Bello, A Bonifazi, M Giannella, G Giorgioni, A Piergentili, R Petrelli, ...
European Journal of Medicinal Chemistry 125, 233-244, 2017
Mandates: US National Institutes of Health
Chemical manipulations on the 1, 4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells
F Del Bello, A Bonifazi, G Giorgioni, W Quaglia, C Amantini, MB Morelli, ...
European Journal of Medicinal Chemistry 168, 461-473, 2019
Mandates: US National Institutes of Health
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders
A Bonifazi, F Del Bello, G Giorgioni, A Piergentili, E Saab, L Botticelli, ...
Medicinal Research Reviews 43 (5), 1607-1667, 2023
Mandates: US National Institutes of Health
Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A1 Adenosine Receptor Agonists
R Petrelli, M Scortichini, C Belardo, S Boccella, L Luongo, F Capone, ...
Journal of Medicinal Chemistry 61 (1), 305-318, 2018
Mandates: Government of Italy
β‐Catenin signaling is important for osteogenesis and hematopoiesis recovery following methotrexate chemotherapy in rats
J Fan, YW Su, M Hassanshahi, CM Fan, Y Peymanfar, A Piergentili, ...
Journal of Cellular Physiology 236 (5), 3740-3751, 2021
Mandates: National Health and Medical Research Council, Australia, National Natural …
Cu (I) Coordination Compounds Conjugated to Au Nanorods for Future Applications in Drug Delivery: Insights in Molecular, Electronic and Cu Local Structure in Solid and Liquid Phase
A Lopez, S Amatori, E Olivieri, I Venditti, G Iucci, C Meneghini, F Bertelà, ...
ChemPhysChem, e202400074, 2024
Mandates: European Commission
Available somewhere: 29
Roles of Wnt/β-catenin signalling pathway in the bony repair of injured growth plate cartilage in young rats
R Chung, D Wong, C Macsai, A Piergentili, F Del Bello, W Quaglia, ...
Bone 52 (2), 651-658, 2013
Mandates: National Health and Medical Research Council, Australia
Underlying susceptibility to eating disorders and drug abuse: genetic and pharmacological aspects of dopamine D4 receptors
L Botticelli, E Micioni Di Bonaventura, F Del Bello, G Giorgioni, ...
Nutrients 12 (8), 2288, 2020
Mandates: Government of Italy
Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
L Chen, Y Zhao, GC Halliday, P Berry, RF Rousseau, SA Middleton, ...
British journal of cancer 111 (4), 716-725, 2014
Mandates: Cancer Research UK
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior
EM Di Bonaventura, L Botticelli, F Del Bello, G Giorgioni, A Piergentili, ...
Pharmacological Research 172, 105847, 2021
Mandates: Government of Italy
1, 3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity
S Franchini, C Sorbi, P Linciano, G Carnevale, A Tait, S Ronsisvalle, ...
European Journal of Medicinal Chemistry 176, 310-325, 2019
Mandates: Government of Italy
Cu (I) and Cu (II) complexes based on lonidamine-conjugated ligands designed to promote synergistic antitumor effects
F Del Bello, M Pellei, L Bagnarelli, C Santini, G Giorgioni, A Piergentili, ...
Inorganic Chemistry 61 (12), 4919-4937, 2022
Mandates: Government of Italy
Adenosine receptors as promising targets for the management of ocular diseases
E Spinozzi, C Baldassarri, L Acquaticci, F Del Bello, M Grifantini, ...
Medicinal Chemistry Research 30, 353-370, 2021
Mandates: Government of Italy
TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation
CJ Drummond, A Esfandiari, J Liu, X Lu, C Hutton, J Jackson, ...
Oncotarget 7 (29), 46203, 2016
Mandates: Cancer Research UK
Synergic stimulation of serotonin 5-HT1A receptor and α2-adrenoceptors for neuropathic pain relief: Preclinical effects of 2-substituted imidazoline derivatives
LDC Mannelli, C Ghelardini, L Micheli, F Del Bello, M Giannella, ...
European Journal of Pharmacology 810, 128-133, 2017
Mandates: Government of Italy
Exploring the Role of N6-Substituents in Potent Dual Acting 5′-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and …
R Petrelli, M Scortichini, S Kachler, S Boccella, C Cerchia, I Torquati, ...
Journal of medicinal chemistry 60 (10), 4327-4341, 2017
Mandates: US National Institutes of Health, Government of Italy
Treatment with 2-pentadecyl-2-oxazoline restores mild traumatic brain injury-induced sensorial and neuropsychiatric dysfunctions
S Boccella, M Iannotta, C Cristiano, FA Iannotti, FD Bello, F Guida, ...
Frontiers in Pharmacology 11, 91, 2020
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program